Yi Yang Yvonne Li

Summary

Affiliation: Berlex Biosciences
Country: USA

Publications

  1. doi request reprint The identification of a small molecule inhibitor that specifically reduces T cell-mediated adaptive but not LPS-mediated innate immunity by T cell membrane-monocyte contact bioassay
    Yi Yang Yvonne Li
    CRBA Inflammation, RBA Dermatology USA, Berlex Biosciences, 2600 Hilltop Drive, Richmond, CA 94804, USA Yvonne
    Immunol Lett 117:114-8. 2008
  2. doi request reprint Targeting leukocyte recruitment in the treatment of psoriasis
    Yi Yang Yvonne Li
    CRBA Inflammation Immunology, Berlex Biosciences, Richmond, CA 94804, USA
    Clin Dermatol 26:527-38. 2008
  3. ncbi request reprint Mouse splenic B lymphocyte activation using different activation stimuli induces in vitro splicing of tumor necrosis factor-alpha nuclear pre-mRNA
    Yi Yang Yvonne Li
    Department of Internal Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, CCSR 2215b, 269 Campus Drive, Stanford, CA 94305 5166, USA
    Mol Immunol 43:613-22. 2006
  4. ncbi request reprint Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha
    Carl K Edwards
    Amgen, Inc, Thousand Oaks, California, USA
    Arthritis Rheum 54:2872-85. 2006
  5. ncbi request reprint CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity
    Parham Mirshahpanah
    TRG Inflammation and Immunology, Bayer Schering Pharma AG, Berlin, Germany
    Exp Dermatol 17:30-4. 2008

Collaborators

Detail Information

Publications5

  1. doi request reprint The identification of a small molecule inhibitor that specifically reduces T cell-mediated adaptive but not LPS-mediated innate immunity by T cell membrane-monocyte contact bioassay
    Yi Yang Yvonne Li
    CRBA Inflammation, RBA Dermatology USA, Berlex Biosciences, 2600 Hilltop Drive, Richmond, CA 94804, USA Yvonne
    Immunol Lett 117:114-8. 2008
    ....
  2. doi request reprint Targeting leukocyte recruitment in the treatment of psoriasis
    Yi Yang Yvonne Li
    CRBA Inflammation Immunology, Berlex Biosciences, Richmond, CA 94804, USA
    Clin Dermatol 26:527-38. 2008
    ..In this review, we will discuss the molecules and mechanisms involved in trafficking of different types of leukocytes and elucidate modes of action as well as therapeutic strategies of existing drugs and drug candidates...
  3. ncbi request reprint Mouse splenic B lymphocyte activation using different activation stimuli induces in vitro splicing of tumor necrosis factor-alpha nuclear pre-mRNA
    Yi Yang Yvonne Li
    Department of Internal Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, CCSR 2215b, 269 Campus Drive, Stanford, CA 94305 5166, USA
    Mol Immunol 43:613-22. 2006
    ....
  4. ncbi request reprint Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha
    Carl K Edwards
    Amgen, Inc, Thousand Oaks, California, USA
    Arthritis Rheum 54:2872-85. 2006
    ....
  5. ncbi request reprint CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity
    Parham Mirshahpanah
    TRG Inflammation and Immunology, Bayer Schering Pharma AG, Berlin, Germany
    Exp Dermatol 17:30-4. 2008
    ..We conclude that blocking CCR4 and CCR10 simultaneously, or their ligands, should be beneficial in the treatment of T-cell-mediated skin diseases...